Recs

1
Player Avatar StockDocStan (< 20) Submitted: 9/7/2011 10:26:09 AM : Outperform Start Price: $91.91 BIIB Score: +33.14

The clear leader in the independent biotechs is NOT likely to stay independent for long. I expect a buyout by Roche or even Pfizer or Merck in the next 6 months.

Report this Post 2 Replies
Member Avatar ikkyu2 (99.26) Submitted: 6/15/2012 8:22:27 PM
Recs: 0

A buyout? At a 33% premium to market, today's buyout price is $50 billion. Which pharma company has that much cash sitting around?

Member Avatar Mega (99.95) Submitted: 6/17/2012 12:46:08 PM
Recs: 0

GlaxoSmithKlineBiogenIdec would be a good company name.

Featured Broker Partners


Advertisement